Found 7 matching trials
A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients
PHASE3A Phase III, Multicenter, open-labeded study to Evaluate Efficacy and Safet...
Location
Beijing Tsinghua Changgung Hospital
Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD
PHASE1This study is to evaluate the single-dose pharmacokinetics (PK) and safety ...
Location
West China Hospital of Sichuan University
Phase 3 Study of Yimitasvir Phosphate Capsules
PHASE3The safety, tolerability and antiviral activity of DAG181/SOF in treatment-...
Location
Beijing Ditan Hospital Affiliated to Capital Medical University
Phase 2 Study of Yimitasvir Phosphate Capsules
PHASE2The safety, tolerability and antiviral activity of DAG181/SOF in treatment-...
Location
Peking University First Hospital
The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects
PHASE1The Safety, Tolerability and Pharmacokinetic Study of Chronic Hepatitis C T...
Location
Peking University First Hospital
To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients
PHASE2A phase II study to evaluate the efficacy and safety in TG-2349 combination...
Location
Peking University Peoples Hospital
To Evaluate PK and Safety Profile of Oral MAD of Separately Using TG-2349, DAG181 or Combination in Healthy Chinese Volunteers
PHASE1To evaluate the drug-drug reactions between TG-2349 and DAG181, and the pha...
Location
Xiangya Hospital Central South University